Form 8-K BIOGEN INC. For: Apr 21
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Stifel Updates Ests on Biogen (BIIB) Following Q1 Report; Affirms at 'Hold'
April 21, 2016 12:36 PM EDTStifel affirms Biogen (Nasdaq: BIIB) at Hold following Q1 results issued earlier Thursday.
Analyst Thomas Shrader offered the following commentary: Biogen presented 1Q16 financial results today,... More
Biogen (BIIB) CEO Scangos Says Co. in Talks for 'Tuck-in' Deals, Later-Stage Assets - Conf. Call
April 21, 2016 8:55 AM EDTBiogen (NASDAQ: BIIB) CEO Scangos says the company is in talks for 'tuck in' deals and later-stage assets, according to commentary from the company's conference call on Thursday.
... More